Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Acuta Capital Partners, Llc
Form 13F · Q2 2026

Acuta Capital Partners, Llc

CIK 1582844Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$143M
Reported book value
23
Positions
12
Quarters on record
Top 50
Positions

Acuta Capital Partners, Llc — holdings

Top 23 positions of 23, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1PRAX Praxis Precision Medicines I82,796−2.5%$28M19.3%
2WHWK Whitehawk Therapeutics Inc4.7M+37.4%$21M15.0%
3TNGX Tango Therapeutics Inc390,949−11.5%$12M8.5%
4STRO Sutro Biopharma Inc270,251+0.3%$9M6.3%
5AVBP Arrivent Biopharma Inc218,694—$8M5.3%
6FDMT 4D Molecular Therapeutics In507,801—$7M4.7%
7DRUG Bright Minds Biosciences Inc92,745−17.2%$7M4.5%
8OCUL Ocular Therapeutix Inc532,481−10.1%$5M3.6%
9ERAS Erasca Inc265,199−25.2%$5M3.4%
10SRZN Surrozen Inc173,395+0.3%$4M3.1%
11ARGX Argenx Se4,705+0.3%$4M3.0%
12MLTX Moonlake Immunotherapeutics215,652+12.5%$4M2.9%
13DSGN Design Therapeutics Inc282,564+93.7%$4M2.8%
14NERV Minerva Neurosciences Inc709,500+0.0%$4M2.7%
15TSHA Taysha Gene Therapies Inc561,808+27.8%$4M2.7%
16AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc115,000—$4M2.6%
17AVTX Avalo Therapeutics Inc186,308+206.4%$3M2.4%
18AMLX Amylyx Pharmaceuticals Inc168,115+11.3%$3M2.1%
19ARTV Artiva Biotherapeutics Inc260,416—$3M1.8%
20CMPX Compass Therapeutics Inc595,213−29.9%$1M0.9%
21UTHR United Therapeutics Corp Del2,224+0.0%$1M0.8%
22CTNM Contineum Therapeutics Inc63,095—$1M0.7%
23LBRX Lb Pharmaceuticals Inc28,919+0.0%$938,5660.7%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.